Charlotte Robinson

DocwireNews

The effects of metabolic surgery versus the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) in patients with chronic kidney disease (CKD) have not been well described. Therefore, Ali Aminian, MD, and colleagues studied the renoprotective advantages of metabolic surgery in patients with obesity and CKD compared to patients who did not have surgery but continuously received GLP-1RA. &nbsp;Participants had type 2 diabetes, obesity (defined as BMI &ge;30 kg/m2), and baseline eGFR 20-60 mL/min/1.73 m&sup2;. Patients who had metabolic bariatric surgery at a large US health system between 2010 and 2017 were compared to nonsurgical patients who continuously received GLP-1RA. &nbsp;The primary endpoint of the study was CKD progression, defined as an eGFR decline of &ge;50% or decline to &lt;15 mL/min/1.73 m2, initiation of dialysis, or kidney transplant. The secondary endpoint was concurrent kidney failure (eGFR &lt;15 mL/min/1.73 m2, dialysis, or kidney transplant) or all-cause mortality. A total of 425 patients were studied, including 183 in the metabolic surgery group and 242 in the GLP-1RA group. The median follow-up period was 5.8 years (IQR, 4.4-7.6).&nbsp;&nbsp;At eight years, the cumulative incidence of the primary endpoint was 21.7% (95% CI, 12.2-30.6) in the surgical group and 45.1% (95% CI, 27.7-58.4) in the nonsurgical group (adjusted HR [aHR], 0.40; 95% CI, 0.21-0.76; P=.006). The cumulative incidence of the secondary composite endpoint at eight years was 24.0% (95% CI, 14.1-33.2) in the surgical group and 43.8% (95% CI, 28.1-56.1) in the nonsurgical group (aHR, 0.56; 95% CI, 0.31-0.99; P=.048).&nbsp;In conclusion, metabolic surgery was significantly associated with a 60% lower risk of progression of kidney damage and a 44% lower risk of kidney failure or death compared to GLP-1RA in patients with type 2 diabetes, obesity, and CKD. &ldquo;Metabolic surgery should be considered as a therapeutic option for patients with CKD and obesity,&rdquo; the authors wrote.&nbsp;Source: <a href="https://doi.org/10.1097/SLA.0000000000006379" target="_blank" rel="noopener">Annals of Surgery</a>.&#8239;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Kidney-Protection Benefits of Metabolic Surgery Versus GLP1-RA in Patients With CKD

Chronic Kidney Disease

A study assessed the kidney benefits of metabolic surgery compared to glucagon-like peptide-1 receptor agonist treatment in patients with obesity and chronic kidney disease (CKD). 

Kidney-Protection Benefits of Metabolic Surgery Versus GLP1-RA in Patients With CKD 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe